Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115095
Chunk: 415

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 415
---
03. |

| (10) | Represents 350,000 shares of Common Stock held directly and 382,717 shares underlying certain warrants to purchase Common Stock, with an exercise price of $0.01 per share, held by Oramed exercisable within 60 days of March 31, 2025. Such warrants held by Oramed are subject to a 9.99% beneficial ownership limitation and the number of shares of Common Stock set forth in the table above give effect to such limitation. The foregoing ownership information for Oramed is based on information supplied by Oramed in a statement on Schedule 13G filed with the SEC on January 17, 2025 that reports its sole voting power and sole dispositive power and a Form 4 filed with the SEC by SCLX JV on January 23, 2025. The business address of Oramed Pharmaceuticals Inc. is 1185 Avenue of the Americas, Third Floor, New York, NY 10036. |

257

<div align='center'>**SELLING SECURITYHOLDERS**</div>

This prospectus relates to the offer and sale from time to time by:

(a) the Selling Stockholders of up to an aggregate of 1,594,207 Resale Shares, consisting of: (i) up to 41,082 Sponsor Shares; (ii) up to 1,513,040 Merger Shares, of which 1,458,263 are held by SCLX JV; and (iii) up to 40,085 Private Warrant Shares issuable pursuant to Private Warrants; and

(b) the Selling Warrantholders, of up to 1,402,955 Private Warrants. In connection with the Reverse Stock Split, the SPAC Warrants (which include the Private Warrants) were adjusted in accordance with their terms such that the number of outstanding SPAC Warrants was unchanged, and each SPAC Warrant now entitles the holder to purchase 1/35th of a share of Common Stock at an exercise price of $402.50 per whole share (provided that in no event shall the holder of any such warrants be entitled, upon the exercise of such warrants, to receive a fractional interest in a share of Common Stock upon such exercise and the Company shall, upon such exercise, round up to the nearest whole number of shares of Common Stock to be issued to such holder).

A description of our relationships with certain of the Selling Securityholders and their affiliates is set